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Abstract
Background:   A family of aspartate-specific cysteinyl proteases, named caspases, mediates
programmed cell death, apoptosis. In this function, caspases are important for physiological
processes such as development and maintenance of organ homeostasis. Caspases are, however,
also engaged in aging and disease development. The factors inducing age-related caspase activation
are not known. Xanthurenic acid, a product of tryptophan degradation, is present in blood and
urine, and accumulates in organs with aging.
Results:  Here, we report triggering of apoptotic key events by xanthurenic acid in vascular
smooth muscle and retinal pigment epithelium cells. Upon exposure of these cells to xanthurenic
acid a degradation of ICAD/DFF45, poly(ADP-ribose) polymerase, and gelsolin was observed,
giving a pattern of protein cleavage characteristic for caspase-3 activity. Active caspase-3, -8 and
caspase-9 were detected by Western blot analysis and immunofluorescence. In the presence of
xanthurenic acid the amino-terminal fragment of gelsolin bound to the cytoskeleton, but did not
lead to the usually observed cytoskeleton breakdown. Xanthurenic acid also caused mitochondrial
migration, cytochrome C release, and destruction of mitochondria and nuclei.
Conclusions:   These results indicate that xanthurenic acid is a previously not recognized
endogenous cell death factor. Its accumulation in cells may lead to accelerated caspase activation
related to aging and disease development.
Background
Xanthurenic acid is formed upon tryptophan degrada-
tion by indoleamine-2,3 dioxygenase (IDO). The end
products of this degradation pathway are, alternatively,
nicotinate and xanthurenic acid. IDO activity is stimulat-
ed by superoxide radicals, liposaccharides and interfer-
on-γ  [1]. Kynurenine aminotransferase (KAT), the
enzyme directly responsible for xanthurenic acid forma-
tion from 3-hydroxykynurenine, is found in the cyto-
plasm and mitochondria, and is highly expressed in the
retina [2,3]. Xanthurenic acid is present in blood and
urine at concentrations of 0.7 and 5-10 µM, respectively
[4,5]. A several - fold increase is observed in vitamin B6
deficiency and some diseases such as tuberculosis [6,7].
Xanthurenic acid's presence in the blood is linked to ma-
laria development, and in the lenses to senile cataract
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formation [8,9,10]. Xanthurenic acid binds covalently to
proteins, leads to their unfolding, and to cell death [11].
Here, we report that xanthurenic acid induces cell death
associated with caspase-3, -8, and -9 activation, nuclear
DNA cleavage, and cytochrome C release. However, cell
death is not associated with cytoskeleton breakdown,
usually observed because of actin depolymerization by
caspase-3-cleaved gelsolin [12].
Results and Discussion
Xanthurenic acid leads to caspase-3 activation in smooth 
muscle cells
Xanthurenic acid induced cell death in a concentration-
dependent manner. Death was associated with caspase-
3 activation (Fig. 1). Caspase-3 can be induced by two
primary pathways: by activation of cell surface receptors
(FAS, TRAIL, TNF), or by activation of a stress response
pathway leading to cytochrome C release from mito-
chondria and caspase-9 activation [13,14,15]. Procas-
pase-3 (CPP32) is cleaved at ASP 175, leading to an
autocatalytic process which liberates the active p17 frag-
ment [16]. In this study, xanthurenic acid-dependent
cleavage of CPP32 was observed by Western blotting
(Fig. 1e), and formation of caspase-3 p17 was detected by
immunostaining (Fig. 1f, Fig. 3a).
Xanthurenic acid provokes degradation of caspase-3 sub-
strates DFF-45, PARP, and gelsolin
Caspase 3 is required for the degradation of DFF45/
ICAD with formation of the carboxy-terminal fragment
p11, which is necessary for DNA cleavage [17,18]. In cells
exposed to xanthurenic acid, DFF45 was cleaved with
generation of the p11 fragment, recognized with an anti-
body directed against full-length DFF45 (Fig. 2a). Proc-
essed DFF45 leads to internucleosomal cleavage, and
indeed the DNA of cells exposed to xanthurenic acid was
fragmented as shown by Hoechst 33342 staining and flu-
orescence microscopy (Fig. 2b). The amount of PARP
protein was increased in xanthurenic acid-exposed cells,
and PARP was degraded to the apoptotic p85 fragment
(Fig. 2c, 3b), which was reported to be formed upon cas-
pase-3 cleavage [19]. Also gelsolin was cleaved in cells in
a xanthurenic acid concentration-dependent manner
with formation of p41, the amino terminal part of gelso-
lin, called "N-half" (Fig. 2d. Fig. 3d,e). The latter is a
product of caspase-3 activity [12, 20]. The p41 fragment
was further degraded, indicating that xanthurenic acid
activated additional enzyme(s) involved in gelsolin
processing. It was reported that N-half leads to depolym-
erization of actin filaments [20].
Apoptosis induced by xanthurenic acid did not cause cy-
toskeleton depolymerization
In the presence of xanthurenic acid the caspase-3
cleaved gelsolin did not cause cytoskeleton breakdown
(Fig. 3d). To the contrary, the elongated cytoskeleton
was strongly stained for N-half of gelsolin, and the stain-
ing increased with xanthurenic acid concentration (Fig.
3d), the condition which led to activation of caspase-3
(Fig. 3a) and caspase-9 (Fig. 3c). N-half contains two
polyphosphoinositide (PIP) binding domains. Phos-
phatidylinositol 4,5-bisphosphate and phosphatidyli-
nositol 3,4-bisphosphate form a stable complex with
gelsolin, which prevents caspase-3 and -9 activation [21].
We prepared a part of N-half containing amino acid res-
idues 162-187 (human sequence of gelsolin), which con-
tains a PIP binding domain in position 162-169, and
raised a polyclonal antibody against the peptide, called
GPIP1. This antibody stained the cytoskeleton of xan-
thurenic acid-exposed cells but not of the control cells
(Fig. 3e). This indicates that after xanthurenic acid-de-
pendent gelsolin cleavage the sequence containing
GPIP1 binds to the cytoskeleton. The cleavage of gelsolin
in the presence of xanthurenic acid did not lead to break-
down of the cytoskeleton (Fig. 3e), in contrast to experi-
ments where gelsolin was overexpressed [12].
Xanthurenic acid induces mitochondrial damage
We observed activation of caspase-9 in cells after expo-
sure to xanthurenic acid, indicating the triggering of a
mitochondrial pathway (Fig. 3c) and release of cyto-
chrome C in the cells exposed to xanthurenic acid (Fig.
4a,b,c). We used Mitotracker CMXRos to detect mito-
chondria and a possible loss of the mitochondrial mem-
brane potential, previously seen when gelsolin had been
cleaved [22]. Mitotracker CMXRos dramatically sensi-
tized mitochondria to xanthurenic acid. Whereas in the
experiments reported above cells were exposed for one
week to xanthurenic acid, 3 hours of exposure to xan-
thurenic acid together with Mitotracker CMXRos suf-
ficed to cause relocalisation of mitochondria from the
nuclear region (Fig. 4d) to the cytoskeleton (Fig. 4e). At
higher xanthurenic acid concentration mitochondria lost
their membrane potential (Fig. 4f,g,h,i,j), released cyto-
chrome C (Fig. 4f) and strong staining for N-half of gel-
solin was observed (Fig. 4f). Under these conditions cells
died within 24 hours.
Effector caspases in demolition phase of xanthurenic acid-
induced apoptosis
In the presence of xanthurenic acid the cell death was as-
sociated with DFF p11 formation, which is characteristic
for caspase-3 activity. Recently, it was reported that exe-
cutioner caspases-3, 6, and 7 play non-redundant roles
during the demolition phase of apoptosis. Caspase-6 and
caspase-7 are not involved in DNA degradation but in
lamin A degradation, and caspase-7 activation provokes
PARP cleavage [23]. Our Western blot analysis showed
that in the presence of xanthurenic acid lamin A cleavage
does not occur in VSMC suggesting that these caspasesBMC Physiology (2001) 1:7 http://www.biomedcentral.com/1472-6793/1/7
are not activated in the presence of this compound. This
suggests that the cleavage of PARP occurred due to cas-
pase-3 activation. Plectin, a cytolinker responsible for
the mechanical stability of the cytoskeleton, is cleaved by
Figure 1
Caspase-3 activation and apoptosis upon xanthurenic acid (XAN) accumulation in vascular smooth muscle
cells (VSMC). a, VSMC after one week of growth in MEM without XAN (left panel), and in the presence of XAN at a con-
centration of 5 µg/ml (right panel). The nuclear DNA fragmentation at 40 µg/ml, see Fig. 2b. b, Concentration of xanthurenic
acid in the cell extract used for Western blot analysis. XAN was determined in the cell extracts as described previously [11].
c, Apoptotic cell death measured as a ratio of the cells with condensed or fragmented nuclei to total nuclei. d, Caspase-3 activ-
ity measured by caspase-3 substrate Ac-DEVD-pNa cleavage, e, Western blot of active caspase-3 in VSMC after exposure to
XAN. Procaspase-3 (CPP32) was cleaved in the presence of XAN with the formation of pl7 and pl2. f, Immunofluorescence
staining for caspase 3 pl7 in control cells (left panel) and in VSMC exposed to 40 µg/ml of XAN for one week (right panel).BMC Physiology (2001) 1:7 http://www.biomedcentral.com/1472-6793/1/7
caspase-8 at ASP 2395. The cytoskeleton lost intermedi-
ary fibers due to plectin cleavage, and cells lost their in-
tegrity. Full-length caspase-8 co-localises with
mitochondria and active caspase-8 is translocated to
plectin [24].
In the presence of xanthurenic acid caspase-8 was acti-
vated in VSMC (Fig. 5a, b). In the control cells caspase-8
was observed in the perinuclear region (Fig. 5a, left pan-
el), and in the presence of the xanthurenic acid the anti-
body directed against caspase-8 stained the whole
cytoskeleton (Fig. 5b, right panel). In the presence of
xanthurenic acid plectin was translocated from the mito-
chondrial region to the cytoskeleton (Fig. 5c, left and
right panel, respectively). Western blot analysis using an
antibody specific for the amino terminus of plectin
showed the formation of the fragment of about 130 kD
characteristic for caspase-8 cleavage. However, the p130
fragment was further degraded, indicating that xan-
thurenic acid activated additional enzyme(s) involved in
plectin processing (not shown). Caspase-8 activation in
the presence of xanthurenic acid is an upstream event for
the cell pathology in the presence of xanthurenic acid.
Downstream caspase-3 can be directly activated by cas-
pase-8 or via the mitochondrial pathway consisting of
the translocation to mitochondria of truncated BID (t-
BID) [25, 26]. In our study, t-BID was translocated in the
presence of xanthurenic acid from the cytoplasm to mi-
tochondria (Fig. 5d, left and right panel respectively) in-
dicating that caspase-8 activation is an upstream event
leading to the observed cytochrome C release, which in
turn can activate caspase-9 by apoptosome formation
[27]. Caspase-8 can be activated by death receptors, or
by an amplification loop with caspase-9 [28, 29, 30]. The
Figure 2
Cleavage of caspase-3 substrates PARP, DFF45/ICAD, and gelsolin in VSMC exposed to xanthurenic acid
(XAN) for one week. DFF45 and PARP were slightly upregulated in the presence of XAN. a, Western blot of DFF45/ICAD.
b, Nuclear fragmentation in control cells (left panel) and VSMC grown in the presence of XAN at 40 µg/ml for one week (right
panel). c, Western blot of PARP. d, Western blot of gelsolin.BMC Physiology (2001) 1:7 http://www.biomedcentral.com/1472-6793/1/7
pathways of caspase-8 activation and cytochrome C re-
lease in the presence of xanthurenic acid are currently
under study in our laboratory.
Conclusions
Our results indicate that an accumulation of the tryp-
tophan metabolite, xanthurenic acid, leads to cleavage of
caspases substrates and apoptosis. Unexpectedly, xan-
thurenic acid-induced apoptosis is associated with an ab-
normal function of cleaved gelsolin. The results indicate
that xanthurenic acid is an important factor involved in
aging and disease development.
Materials and Methods
Reagents
We used the following polyclonal antibodies from Santa
Cruz Biotechnology Inc. CA, USA: antibodies against full
length caspase-3, caspase-8, DFF 45/ICAD, and PARP,
amino terminus of gelsolin, plectin, cytochrome C, and
carboxy terminus of BID. Immunocytochemistry was
performed using primary antibodies against active cas-
pase-3 pl7 (BD PharMingen, San Diego, CA, USA, and
Promega, Madison, USA), active caspase-9 (BioLabs
Inc., New England, UK), and anti-PARP p85 (Promega).
Secondary IgG-Texas Red, fluoresceine (FITC)-conju-
gated antibodies and Mitotracker CMXRos were from
Molecular Probes, Leiden, The Netherlands. Other rea-
gents were from Sigma if not specified.
Figure 3
Detection of apoptotic proteins by immunofluores-
cence in human retinal pigment epithelium cells
after exposure to 20 µM xanthurenic acid for one
week (magnification 200-fold). Panels a-c from left to
right represent immunodetection of apoptotic protein with
respective antibody, staining of nucleus with Hoechst, and
merge of both. No staining for these enzymes was observed
in control cells. a, Detection of active caspase-3 pl7. b,
Detection of PARP p85. c, Detection of active caspase-9.
Panel  d, Detection of N-half of gelsolin bound to the
cytoskeleton. From left to right: without xanthurenic acid,
with 10 µM xanthurenic acid, with 20 µM xanthurenic acid.
e, Detection of cleaved gelsolin containing polyphosphoi-
nositide binding domain by antibody directed against GPIP1
in apoptotic cells. From left to right: first two panels, control
cells; Hoechst staining, no staining with antibody directed
against GPIP1. Next two panels: cells incubated for one week
with 20 µM xanthurenic acid; Hoechst staining, staining with
antibody against GPIP1.
Figure 4
Analysis of mitochondria in human pigment retinal
epithelial cells exposed to xanthurenic acid. Panels a-c
(magnification 200-fold), Cytochrome C release in the pres-
ence of 20 µM xanthurenic acid for one week. a, Staining for
cytochrome C. b, Hoechst staining. c, Merge of both. Panels
d-f (magnification 800-fold), Mitochondria were stained with
Mitotracker CMXRos, and cells were stained with antibody
against gelsolin (N-half). d, Control cells, e, Cells exposed to
5 µM xanthurenic acid (see Methods), f, Cells exposed to 20
µM xanthurenic acid. Lack of staining with Mitotracker
CMXRos, co-staining for cytochrome C (orange), and N-half
of gelsolin (green). Panels g-h (magnification 4000-fold), g,
Single control mitochondrion stained for cytochrome C. h,
Single mitochondrion stained with Mitotracker CMXRos. i,
Same as in j, but staining with Mitotracker CMXRos. j, Stain-
ing for cytochrome C in cells exposed to 20 µM xanthurenic
acid.BMC Physiology (2001) 1:7 http://www.biomedcentral.com/1472-6793/1/7
Preparation of polyclonal antibody directed against GPIP1
GPIP1, a peptide comprising 25 aminoacids correspond-
ing to residue 162-187 (NH2-KSGLKYKKGGVA-
SGFKHVVPNEVVV-COOH) in human gelsolin sequence
(Swiss-Prot P06396) was synthetized (95% purity) by
MWG AG Biotechnology, Ebersberg, Germany. 200 µg of
the peptide were injected 3 times into rabbits in 3 weeks
intervals. Sera were used for Western blots and immun-
oflourescence in a 1:100 dilution.
Cell culture
Primary vascular smooth muscle cells (VSMCs) were
prepared from porcine aorta. Retinal pigment epitheli-
um (RPE) cells obtained from a 59 years old eye donor
were provided by Dr. M. Boenke, Department of Oph-
thalmology, University Hospital, Bern. The cells were
cultivated in Minimal Essential Medium (MEM) with
Earle's salts (Life Sciences, Basel, Switzerland). Cells
were grown under a humidified atmosphere of 5% CO2 in
air at 37°C in MEM supplemented with 10% fetal bovine
serum, penicillin (10 U/ml), streptomycin (10 µg/ml)
and fungizone (250 ng/ml). When confluent, they were
incubated for one week in MEM or MEM supplemented
with xanthurenic acid. A 20 mM stock solution of xan-
thurenic acid was prepared in 0.5 M NaHCO3, and dilut-
ed in 0.05 M NaHCO3.
Cytotoxicity and apoptosis assay
Cells were observed with differential interference con-
trast optics on a Zeiss Avionert 405 M inverted micro-
scope. Cell viability was determined by staining the cells
with Hoechst 33342 and propidium iodide (PI) (Juro,
Switzerland) using 50 µg/ml of each dye. Fragmented,
apoptotic, nuclei were observed with excitation at 350
nm, and necrotic nuclei at 530 nm. The extent of apopto-
sis was estimated by examination of 300 nuclei from
each sample.
Cell lysis and immunobloting
Cell were washed twice with cold 0.01 M phosphate buff-
er, pH 7.4. For Western blotting, cells were lysed in buff-
er containing 50 mM Tris (pH 8.0), 150 mM NaCl, 1
%Triton X-100, and the following protease inhibitors: 1
mM phenyl-methylsulfonyl fluoride, and leupeptin,
aprotinin, and pepstatin, each at 1 µg/ml. The concentra-
tion of proteins was calculated from the absorption max-
imum at 280 nm, as described previously [11], and
concentration of xanthurenic acid from its absorptiom
maximum at 342 nm (ε M 6500). The lysate was centri-
fuged for 10 min at 14 000 g, and the supernatant was
boiled in loading-buffer for 5 min. Proteins (50 µg per
lane) were separated by SDS-PAGE containing 10 or
12.5% acrylamide. After transfer to Hybond ECL mem-
brane (Amersham Pharmacia Biotech AB, Uppsala, Swe-
den) the proteins were probed with the appropriate
antibodies. Chemilunimescence ECL system (Amersham
Pharmacia Biotech AB, Uppsala, Sweden) was used for
the detection of peroxidase-conjugated secondary anti-
body.
Figure 5
Analysis of caspase-8 and caspase-8 substrate-pro-
teins, plectin and BID, in pig VSMC.  a, Western blot
analysis of caspase-8 in the cells after exposure to xan-
thurenic acid (XAN) for one week. Procaspase-8 was cleaved
in the presence of XAN with the formation of pl8. Panels b-
d, (magnification 800-fold) immunodetection of caspase-8
and plectin and BID in control cells (left panels), and after
exposure to 40 µM of xanthurenic acid for 96 hours (right
panels), b, detection of caspase-8. c, detection of plectin. d,
detection of BID.BMC Physiology (2001) 1:7 http://www.biomedcentral.com/1472-6793/1/7
Caspase-3 activity
Caspase 3 cleavage activity is based on the spectrophoto-
metric detection of the chromophore p-nitroaniline at
405 nm after cleavage from the substrate Ac-Asp-Glu-
Val-Asp-p-nitroaniline (Ac-DEVD-pNa) (Bachem, Basel,
Switzerland). Caspase activity was measured after 1 hour
of incubation of 200 µM Ac-DEVD-pNa at 37°C with the
cell extract containing 25 mM HEPES (pH 7.5), 300 mM
NaCI, 10 mM KCl, 1.5 mM MgCl2, 10% glycerol, 0.1 mM
DTT, 1 mM phenylmethylsulfonylfluoride, and apro-
tinin, leupeptin, and pepstatin, each at 1 µg/ml.
Immunofluorescence
Cells grown on glass coverslips were fixed for 10 min at
room temperature in 4% paraformaldehyde in 0.1 M
PIPES, pH 6.8, washed in PBS and permeabilized for 5
min in PIPES containing 0.05% saponin (65 µl per cov-
erslip), washed in PBS, incubated with cold aceton for
additional fixing and permeabilisation, and again
washed in PBS. Cells were incubated for 1.5 hour with the
first antibody diluted in PBS containing 1% bovine serum
albumine, and after washing incubated for 1.5 hour with
the secondary antibody. The coverslips were then
washed in PBS and incubated for 10 min with 65 µl of 4%
paraformaldehyde solution containing 1 µl of Hoechst
33342 dye (1 mg/ml), washed in PBS, and incubated with
Antifade Kits (Molecular Probes, Leiden, The Nether-
lands) according to the supplier's instruction. Staining of
mitochondria was performed using Mitotracker
CMXRos, as follows: confluent cells culture were pre-in-
cubated without or with xanthurenic acid in MEM medi-
um for 3 hours. The medium was removed and replace
with medium containing 100 nM Mitotracker CMXRos.
After an incubation for 45 min Mitotracker CMXRos was
removed and replaced by MEM medium. The cell were
cultivated for the next 20 hours, stained additionally
with antibody against gelsolin (as above) and then ob-
served by fluorescence microscopy.
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